Skip to main content

What is the ‘triple action’ of Becodefence?

It ‘defuses’ pollen already inside the nose. Its free fatty acids in the formula are known for reducing the allergenic potential of pollen, i.e. they inhibit the release of allergens from pollen onto the mucosa. As such, they ‘defuse’ the pollen by reducing the allergenic activity.

Becodefence’s fine mist resettles as a barrier on the nasal mucosa, preventing pollen that will be inhaled from contacting the nasal mucosa and subsequently attaching to mast cells and triggering an allergic reaction.

The sesame oil in Becodefence stimulates the clearance of the pollen out of the nose, i.e. the mucociliary process.




*IRI hay fever remedies unit sales 52 w/e 23rd Feb 2019. For verification please email

(1) Del Cuvillo A, Mullol J, Bartra J, Dvila I, Juregui I, Montoro J, Sastre J, Valeron AL. Comparative pharmacology of the H1 antihistamines. J Invest Alergol Clin Immunol 2006;16(S1):3-12.

(2) Schran HF, Petryk L, Chang CT, O’Connor R, Gelbert MB. The pharmacokinetics and bioavailability of clemastine and phenylpropanolamine in single-component and combination formulations. J Clin Pharmacol 1996;36:911-922.

(3) Simons FE, Simons KJ. Clinical pharmacology of new histamine H1 receptor antagonists. Clin Pharmacokinet 1999;36(5):329-52.

(4) Georgitis JW, Meltzer EO, Kaliner M, Weiler J, Berkowitz R. Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge. Ann Allergy Asthma Immunol 2000;84(4):451-459.

Beconase Hay fever and Beconase Hay fever Relief for Adults 0.05% Nasal Spray contains beclometasone dipropionate. For the treatment of hay fever in adults aged 18 and over. Becodefence, Becodefence Kids and Becodefence Plus are medical devices. Always read the leaflet.